DEM BioPharma is a company that works to eradicate cancer by targeting new checkpoints in the innate immune system. Its platform is used to systematically and objectively identify unexplored DEM and EM signals by intercellular CRISPR screening using tumor cells, primary macrophages and other effector cells of innate immunity.